Percutaneous transluminal angioplasty against arteriosclerosis obliterans in dialysis patients

  • Authors:
    • Kenji Tsuchida
    • Yoshiaki Takemoto
    • Kazunobu Sugimura
    • Rikio Yoshimura
    • Tatsuya Nakatani
  • View Affiliations

  • Published online on: March 1, 2003     https://doi.org/10.3892/ijmm.11.3.365
  • Pages: 365-368
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The incidence of peripheral arteriosclerosis is on the increase in chronic hemodialysis patients. Recently, the intervention (IV) treatment is conducted to deal with this problem. IV was performed in 4 dialysis patients against the complication of arteriosclerosis obliterans (ASO) but the result was unsuccessful in 3 of them. These 3 failure cases were investigated to find the problems associated with percutaneous transluminal angioplasty (PTA). Cases 1, 2 and 3 had intermittent claudication while case 4 had gangrenous toes as the major complaint. The symptoms in these cases were attributable to 90-100% stenosis and occlusion of superficial femoral artery, bilateral iliac arteries, bilateral superficial femoral-popliteal artery, branch of right iliac artery and left iliac artery region, respectively. IV was successful in case 1 but failed in cases 2 and 4 because the catheter itself did not go through due to the severe stenosis of vessel or the procedure of forcefully dilating the vessel caused dispersion of minute thrombi. In case 3, acute myocardial infarction occurred at 10 h after successful IV, resulting in sudden death. In view of the extent of invasion, IV is a treatment method selected against ASO in dialysis patients. However, the method has a high risk of causing thrombus formation, vessel rupture and organ failure. In this regard, it is advisable to evaluate the systemic condition and conduct IV if the extent of stenosis is mild.

Related Articles

Journal Cover

March 2003
Volume 11 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tsuchida K, Takemoto Y, Sugimura K, Yoshimura R and Nakatani T: Percutaneous transluminal angioplasty against arteriosclerosis obliterans in dialysis patients. Int J Mol Med 11: 365-368, 2003
APA
Tsuchida, K., Takemoto, Y., Sugimura, K., Yoshimura, R., & Nakatani, T. (2003). Percutaneous transluminal angioplasty against arteriosclerosis obliterans in dialysis patients. International Journal of Molecular Medicine, 11, 365-368. https://doi.org/10.3892/ijmm.11.3.365
MLA
Tsuchida, K., Takemoto, Y., Sugimura, K., Yoshimura, R., Nakatani, T."Percutaneous transluminal angioplasty against arteriosclerosis obliterans in dialysis patients". International Journal of Molecular Medicine 11.3 (2003): 365-368.
Chicago
Tsuchida, K., Takemoto, Y., Sugimura, K., Yoshimura, R., Nakatani, T."Percutaneous transluminal angioplasty against arteriosclerosis obliterans in dialysis patients". International Journal of Molecular Medicine 11, no. 3 (2003): 365-368. https://doi.org/10.3892/ijmm.11.3.365